Virtual self-management education for type 1 diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates a virtual health care intervention designed to improve glycemic control in individuals with type 1 diabetes (T1D) by providing frequent, low-touch support. It is a pragmatic multicenter, open-label, randomized trial involving 580 participants from 10 specialized T1D centers in Ontario. The intervention aims to reduce the burden of traditional in-person visits while enhancing patient engagement and metabolic control through digital means.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Outpatients ≥18 years of age
2. Physician diagnosis of type 1 diabetes
3. Currently on an insulin pump or using multiple daily insulin injections.
4. HbA1c ≥ 7.5% on most recent laboratory report or estimated from CGM/FGM\* report, within the last 4 months

   \*14 day look back window, with a wear rate of 70%, based on Estimated A1c or Glucose management Indicator (GMI)
5. Has access to a mobile device or computer/tablet with a video camera
6. Seen for at least one visit in the previous 6 months by participating certified diabetes educator at the selected diabetes clinic OR If a transitioning patient: Currently enrolled in a diabetes program below AND had at least one visit or touch-point prior in the previous 6 months by participating certified diabetes educator at on of our participating diabetes clinics
7. OHIP coverage
8. Currently using an active email address or be willing to obtain an email address
9. Has consistent and reliable access to internet
10. Willing and able to comply with scheduled in-person and virtual visits for 6 month intervention period

Exclusion Criteria:

1. Diagnosed with non-Type 1 diabetes
2. Unable to use a computer/tablet or mobile phone
3. Pregnant
4. On dialysis
5. Unable to fluently speak or read English (self-reported)

Where it's running

• Waterloo Regional Health Network
  Kitchener, Ontario, Canada Recruiting
• Mackenzie Health
  Richmond Hill, Ontario, Canada Recruiting
• Sunnybrook Health Sciences Centre
  Toronto, Ontario, Canada Recruiting
• St. Michael's Hospital, Unity Health Toronto
  Toronto, Ontario, Canada Recruiting
• Mount Sinai Hospital
  Toronto, Ontario, Canada Recruiting
• Toronto General Hospital
  Toronto, Ontario, Canada Recruiting

Study contacts

• Principal investigator: Gillian Booth, MD — Unity Health Toronto
• Study coordinator: Stephanie de Sequeira, MPH
• Email: stephanie.desequeira@unityhealth.to
• Phone: 416-864-6060

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Continuous Glucose Monitor Accuracy and Safety in Adults with Type 1 Diabetes

  This study tests a new real-time CGM system in adults with type 1 diabetes to see if its readings match venous blood glucose measurements.

  Recruiting SiBionics, Co, Ltd · Zibo, Shandong · NCT07745244

• Thrive With Type 1 Diabetes: A Behavioral Program to Improve Glucose and Sleep

  A behavioral program is being tested to see if it helps adults with type 1 diabetes better manage their sleep and glucose targets.

  Recruiting at 2 sites Emory University · Atlanta, Georgia and 1 other locations · NCT07522866

• Cardiometabolic effects of non-nutritive sweeteners in Type 1 diabetes

  This study tests whether non-nutritive sweeteners in a 12-ounce cherry Gatorade drink affect blood sugar control and cardiovascular markers in teens and young adults with Type 1 diabetes.

  Recruiting Medical College of Wisconsin · Milwaukee, Wisconsin · NCT07434544

• Wearable continuous glucose and ketone monitor for adults with type 1 diabetes

  This trial will test if a new wearable device can continuously and accurately measure glucose and ketone levels in adults with type 1 diabetes.

  Recruiting at 2 sites Henan University of Science and Technology · Shijiazhuang, Hebei and 1 other locations · NCT07139808

• Tirzepatide for obesity in people with type 1 diabetes

  This trial will test whether tirzepatide helps adults with type 1 diabetes and obesity lose weight and is safe for them.

  Recruiting Phase 4 Dasman Diabetes Institute · Kuwait City, Sharq · NCT07096908

• New real-time continuous glucose monitor accuracy and safety in adults with type 1 diabetes

  This project will test a new real-time continuous glucose monitor to see if its sensor readings match lab venous plasma (YSI) measurements in adults with type 1 diabetes.

  Recruiting Henan University of Science and Technology · Luoyang, Henan · NCT07092761

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.